Sage Therapeutics’ Post

View organization page for Sage Therapeutics, graphic

105,557 followers

This morning, we provided an update on our #HuntingtonsDisease program. Read the latest news here: https://bit.ly/4egp7ZQ

Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease | Sage Therapeutics, Inc.

Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease | Sage Therapeutics, Inc.

investor.sagerx.com

Ellie Au, PhD

Director of Innovation & New Product Development and Project Management

4mo

This is awesome !!!

Like
Reply
Timmy Garde

Life Sciences Trailblazer, Chief Growth Officer, Disrupter, Board Member, Entrepreneur, Advisor, Mentor, Rapid Growth, M&A, Startups, Landmark Products, PM360 Elite & PharmaVOICE Top 100

4mo

Keep its going Sage Therapeutics team!

Like
Reply
Lauren Morrow

Ph.D. Chemistry Professional | Black Belt | Innovation and Project Management | Leading Projects with Positive Impacts on People and the World

4mo

Fantastic news!

Like
Reply
Nivea Aponte

Director, QA PD at Catalent Pharma Solutions

3mo

Congratulations!

Like
Reply
Lana Garafola

Executive Medical Director at Sage Therapeutics

4mo

Congratulations!!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics